ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,323, issued on Aug. 4, was assigned to Kymab Ltd. (Cambridge, Great Britain).
"Antagonists" was invented by Volker Germaschewski (Cambridge, Great Britain), Igor Theurl (Cambridge, Great Britain), Joana De Abreu Carvalho (Cambridge, Great Britain), Morgane Marie Lecointre (Cambridge, Great Britain), Jonathan Leslie Papworth (Cambridge, Great Britain), Luke Thomas Bayliss (Cambridge, Great Britain) and Verena Petzer (Cambridge, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to Bone Morphogenetic Protein 6 (BMP6) antagonists, such as antibodies and fragments, as well as methods, uses and combinations."
The patent wa...